Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastro-enteropancreatic neuroendocrine tumor × Granulocyte Colony-Stimulating Factor × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Myelodysplastic Syndromes 8 Leukemia, Biphenotypic, Acute 6 Burkitt Lymphoma 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Hodgkin Disease 4 Recurrence 3 Multiple Myeloma 3 Lymphoma, Large B-Cell, Diffuse 3 Hematologic Neoplasms 3 Breast Neoplasms 3 Myeloproliferative Disorders 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Anemia, Refractory, with Excess of Blasts 2 Teratoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Primary Myelofibrosis 1 Osteosarcoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1

Interventions

lutetium Lu 177 dotatate 3 pasireotide 2 Octreotide 2 lanreotide 1 copper dotatate CU-64 1 abemaciclib 1 Sunitinib 1 Receptor-Like Protein Tyrosine Phosphatases, Class 2 1 Lutetium-177 1 Lutetium 1 Everolimus 1 E-7386 1 Cryotherapy 1 Acupuncture Therapy 1 Acupressure 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡